title: Effect of lymph node micrometastases on prognosis of gastric carcinoma.
abstract: OBJECTIVE
  To evaluate the relationship between lymph node micrometastases and prognosis of patients with gastric carcinoma and to evaluate the significance of the new assessment of nodal status in determining the pN categories in the 5th edition of the UICC TNM classification.
  
  
  METHODS
  A total of 850 lymph nodes from 30 patients with gastric carcinoma who underwent gastrectomy with lymphadenectomy were assessed by reverse transcription polymerase chain reaction assay in addition to histologic examination. Cytokeratin-20 gene marker was used in this assay.
  
  
  RESULTS
  Routine examination by HE staining confirmed metastasis in 233 lymph nodes from 20 patients. All these 233 lymph nodes were cytokeratin-20 positive. Moreover, lymph node micrometastases were detected in an additional 67 lymph nodes in 12 of these 20 patients. Lymph node micrometastases were also detected in 10 lymph nodes from 2 of 10 patients who had no obvious metastases identified by HE staining. Totally, lymph node micrometastases were identified by the reverse transcription polymerase chain reaction assay in 77 (12.5%) lymph nodes from 14 (46.7%) patients with gastric carcinoma. Of 27 patients who underwent curative resection, 7 (25.9%) were up-staged (from IB stage to II stage in 1 patient, from IB stage to IIIA stage in 1 patient, from II stage to IIIA stage in 1 patient, from IIIA stage to IIIB stage in 1 patient, from IIIA stage to IV stage in 1 patient, from IIIB stage to IV stage in 2 patients). In a median follow-up of 32 (range 8-36) mo, Kaplan-Meier survival analysis showed significant improvements in median survival (22.86 +/- 3.17 mo, 95% CI: 16.64-29.08 mo vs 18.00 +/- 7.4 mo, 95% CI: 3.33-32.67 mo) of patients with negative lymph node micrometastases over patients with positive lymph node micrometastases (log-rank, P < 0.05).
  
  
  CONCLUSIONS
  Lymph node micrometastases have a significant impact on the current staging system of gastric carcinoma, and are significant risk factors for prognosis of patients with gastric carcinoma.
authors: Department of General Surgery, Guangdong Provincial People's Hospital, Guangzhou 510080, Guangdong Province, China. ljhde@163.com
authors: Ze-Yu
authors: ZY
authors: Wu
authors: Jing-Hua
authors: JH
authors: Li
authors: Wen-Hua
authors: WH
authors: Zhan
authors: Yu-Long
authors: YL
authors: He
authors: Jin
authors: J
authors: Wan
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000032:analysis; D002277:Carcinoma / Q000235:genetics / Q000473:pathology* / Q000601:surgery; D018450:Disease Progression; D005260:Female; D005743:Gastrectomy; D006801:Humans; D053208:Kaplan-Meier Estimate; D053554:Keratin-20 / Q000032:analysis; D008207:Lymphatic Metastasis / Q000235:genetics / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013274:Stomach Neoplasms / Q000235:genetics / Q000473:pathology* / Q000601:surgery
chemical_list: D015415:Biomarkers; D053554:Keratin-20
references: World J Surg. 2003 Apr;27(4):455-9
references: 12658492
references: J Am Coll Surg. 1998 Dec;187(6):597-603
references: 9849732
references: Gastric Cancer. 1999 Aug;2(2):95-100
references: 11957080
references: Anticancer Res. 2006 Sep-Oct;26(5B):3621-5
references: 17094376
references: Anticancer Res. 2003 Jul-Aug;23(4):3499-503
references: 12926097
references: World J Gastroenterol. 2006 Feb 28;12(8):1182-6
references: 16534868
references: Cancer. 2001 Oct 15;92(8):2056-64
references: 11596020
references: World J Gastroenterol. 2006 May 14;12(18):2941-4
references: 16718824
references: Cancer. 2000 Feb 15;88(4):921-32
references: 10679663
references: Oncology. 2006;70(2):90-6
references: 16601367
references: Zentralbl Chir. 1999;124(12):1087-90
references: 10670093
references: Gastric Cancer. 2007;10(1):39-44
references: 17334717
references: Br J Cancer. 2003 Aug 18;89(4):676-80
references: 12915877
references: J Surg Oncol. 2004 Jul 15;87(1):32-8
references: 15221917
references: J Am Coll Surg. 2006 Feb;202(2):223-30
references: 16427546
references: Cancer. 2001 Aug 15;92(4):753-60
references: 11550144
references: Ann Surg Oncol. 2007 May;14(5):1688-93
references: 17245613
references: Surgery. 2002 Jun;131(6):630-5
references: 12075175
references: Cancer. 2002 Jun 1;94(11):2867-73
references: 12115374
references: Ann Surg Oncol. 2002 Oct;9(8):771-4
references: 12374660
references: Ann Surg Oncol. 2007 Feb;14(2):306-16
references: 17091329
references: Hepatogastroenterology. 1999 May-Jun;46(27):2096-9
references: 10430404
references: J Surg Oncol. 2000 Mar;73(3):153-7
references: 10738269
references: Chirurgia (Bucur). 2006 Jul-Aug;101(4):375-84
references: 17059148
references: Cancer. 1997 Mar 15;79(6):1069-76
references: 9070482
references: Gastric Cancer. 2000 Sep 29;3(2):91-96
references: 11984717
references: J Pathol. 2000 Sep;192(1):19-25
references: 10951395